Does Wellpoint Texas, INC. require prior authorization for Tazicef?
Wellpoint Texas, INC. does not require prior authorization for Tazicef on the Medicare Part D plans that cover it.
No covering plan from this payer files a prior-authorization requirement for this drug.
By product strength
| RxNorm product | Plans covering | Require prior auth | Step therapy | Qty limit | Status |
|---|---|---|---|---|---|
| ceftazidime 1000 MG Injection [Tazicef]1659292 | 16 / 16 | 0 | 0 | 0 | No prior authorization |
| ceftazidime 2000 MG Injection [Tazicef]1659294 | 16 / 16 | 0 | 0 | 0 | No prior authorization |
| ceftazidime 200 MG/ML Injectable Solution [Tazicef]206423 | 16 / 16 | 0 | 0 | 0 | No prior authorization |
Product names come from RxNorm (U.S. National Library of Medicine).
Plan-by-plan detail — ceftazidime 1000 MG Injection [Tazicef]
Tazicef has 3 products in the corpus; this table is for ceftazidime 1000 MG Injection [Tazicef], the one carried on the most plans. The product table above covers every strength.
| Plan | Contract | Tier | Prior auth | Step therapy | Qty limit |
|---|---|---|---|---|---|
| Wellpoint Chronic Care 2 (HMO-POS C-SNP) | H2593-006 | 2 | No | No | No |
| Wellpoint Dual Advantage 2 (HMO D-SNP) | H2593-032 | 4 | No | No | No |
| Wellpoint Full Dual Advantage (HMO D-SNP) | H2593-053 | 4 | No | No | No |
| Wellpoint Full Dual Advantage 2 (HMO D-SNP) | H2593-048 | 4 | No | No | No |
| Wellpoint Full Dual Advantage 2 (HMO D-SNP) | H2593-051 | 4 | No | No | No |
| Wellpoint Full Dual Advantage Aligned (HMO D-SNP) | H2593-044 | 4 | No | No | No |
| Wellpoint Full Dual Advantage Aligned (HMO D-SNP) | H2593-045 | 4 | No | No | No |
| Wellpoint Full Dual Advantage Aligned (HMO D-SNP) | H2593-046 | 4 | No | No | No |
| Wellpoint Full Dual Advantage Aligned (HMO D-SNP) | H2593-047 | 4 | No | No | No |
| Wellpoint I CareMore Home Care 2 (HMO I-SNP) | H2593-003 | 2 | No | No | No |
| Wellpoint I CareMore Kidney Care (HMO-POS C-SNP) | H2593-040 | 2 | No | No | No |
| Wellpoint Kidney Care (HMO-POS C-SNP) | H2593-031 | 4 | No | No | No |
| Wellpoint Kidney Care (HMO-POS C-SNP) | H2593-043 | 4 | No | No | No |
| Wellpoint Lung Care 2 (HMO-POS C-SNP) | H2593-005 | 2 | No | No | No |
| Wellpoint Medicare Advantage 2 (HMO-POS) | H2593-001 | 2 | No | No | No |
| Wellpoint Medicare Advantage 2 (HMO-POS) | H2593-029 | 4 | No | No | No |
- Effective
- 2026-06-30
- Retrieved
- 2026-07-19
- SHA-256
- e626e6bcda1aa6a0071e6f0df6bafe686ae41842cdf0a9feffdc649b6d3ff3ae
We publish the hash of the exact file we ingested so any answer can be audited against the bytes CMS served that day.
Tazicef at other payers
Administrative information only. Benefily reports what a payer has published in its own prior-authorization policy as of the effective date shown. It is not medical advice, not a coverage or payment guarantee, and not an authorization. Requirements vary by plan, place of service and member benefits — always verify with the payer before rendering service.